AVAH
Income statement / Annual
Last year (2024), Aveanna Healthcare Holdings Inc.'s total revenue was $2.02 B,
an increase of 6.82% from the previous year.
In 2024, Aveanna Healthcare Holdings Inc.'s net income was -$10.93 M.
See Aveanna Healthcare Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/28/2024 |
12/30/2023 |
12/31/2022 |
01/01/2022 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$2.02 B |
$1.90 B |
$1.79 B |
$1.68 B |
$1.50 B |
$1.38 B |
$1.25 B |
| Cost of Revenue |
$1.39 B
|
$1.30 B
|
$1.23 B
|
$1.14 B
|
$1.04 B
|
$964.81 M
|
$859.35 M
|
| Gross Profit |
$635.54 M
|
$595.43 M
|
$553.23 M
|
$542.40 M
|
$454.52 M
|
$419.25 M
|
$394.32 M
|
| Gross Profit Ratio |
0.31
|
0.31
|
0.31
|
0.32
|
0.3
|
0.3
|
0.31
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$464.74 M
|
$483.95 M
|
$427.77 M
|
$354.77 M
|
$341.00 M
|
$321.84 M
|
| Selling & Marketing Expenses |
$0.00
|
$8.57 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$495.76 M
|
$473.30 M
|
$483.95 M
|
$427.77 M
|
$354.77 M
|
$341.00 M
|
$321.84 M
|
| Other Expenses |
$0.00
|
$115.66 M
|
$36.11 M
|
$20.21 M
|
$17.94 M
|
$16.64 M
|
-$13.74 M
|
| Operating Expenses |
$495.76 M
|
$587.36 M
|
$520.06 M
|
$447.98 M
|
$372.71 M
|
$357.64 M
|
$339.71 M
|
| Cost And Expenses |
$1.88 B
|
$1.89 B
|
$1.75 B
|
$1.58 B
|
$1.41 B
|
$1.32 B
|
$1.20 B
|
| Interest Income |
$498,000.00
|
$327,000.00
|
$679,000.00
|
$253,000.00
|
$345,000.00
|
$207,000.00
|
$594,000.00
|
| Interest Expense |
-$156.60 M
|
$153.25 M
|
$99.94 M
|
$68.93 M
|
$82.98 M
|
$92.30 M
|
$75.54 M
|
| Depreciation & Amortization |
$10.78 M
|
$30.10 M
|
$38.82 M
|
$35.39 M
|
$30.22 M
|
$27.01 M
|
$11.94 M
|
| EBITDA |
-$172.75 M |
$44.35 M |
-$517.28 M |
-$9.26 M |
$22.13 M |
$44.28 M |
$96.11 M |
| EBITDA Ratio |
-0.09
|
0.02
|
0.04
|
0.08
|
0.08
|
0.05
|
0.04
|
| Operating Income Ratio |
0.07
|
0
|
0.01
|
0.06
|
0.05
|
0.03
|
0.03
|
| Total Other Income/Expenses Net |
-$134.72 M
|
-$147.07 M
|
-$21.54 M
|
-$77.47 M
|
-$48.25 M
|
-$113.98 M
|
-$88.69 M
|
| Income Before Tax |
$5.07 M
|
-$139.00 M
|
-$663.81 M
|
-$113.58 M
|
-$51.73 M
|
-$75.03 M
|
-$49.66 M
|
| Income Before Tax Ratio |
0
|
-0.07
|
-0.37
|
-0.07
|
-0.03
|
-0.05
|
-0.04
|
| Income Tax Expense |
-$16.00 M
|
-$4.47 M
|
-$1.78 M
|
$3.47 M
|
$5.32 M
|
$1.49 M
|
-$2.51 M
|
| Net Income |
-$10.93 M
|
-$134.52 M
|
-$662.03 M
|
-$117.04 M
|
-$57.05 M
|
-$76.52 M
|
-$47.15 M
|
| Net Income Ratio |
-0.01
|
-0.07
|
-0.37
|
-0.07
|
-0.04
|
-0.06
|
-0.04
|
| EPS |
-0.0567 |
-0.71 |
-3.57 |
-0.63 |
-0.31 |
-0.41 |
-0.26 |
| EPS Diluted |
-0.0567 |
-0.71 |
-3.57 |
-0.63 |
-0.31 |
-0.41 |
-0.26 |
| Weighted Average Shares Out |
$192.89 M
|
$189.96 M
|
$185.55 M
|
$184.73 M
|
$185.90 M
|
$185.90 M
|
$180.16 M
|
| Weighted Average Shares Out Diluted |
$192.89 M
|
$189.96 M
|
$185.55 M
|
$184.73 M
|
$185.90 M
|
$185.90 M
|
$180.16 M
|
| Link |
|
|
|
|
|
|
|
